Edwards Lifesciences Enterprise Value over EBIT Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 135.64  1.97  1.47%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value over EBIT of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earning Before Interest and Taxes USD.
Enterprise Value over EBIT  10 Years Trend  
Slightly volatile
 Enterprise Value over EBIT 

Edwards Lifesciences Enterprise Value over EBIT Over Time

2016-12-31  26.00 
2017-12-31  26.00 
2018-12-31  30.59 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  32.05
Geometric Mean  24.41
Coefficient Of Variation  112.76
Mean Deviation  18.29
Median  26.00
Standard Deviation  36.13
Sample Variance  1,306
Range  139.00
R Value (0.39)
Mean Square Error  1,210
R Squared  0.15
Significance  0.19
Slope (3.60)
Total Sum of Squares  15,668

Currently Trending

Purchased over 30 shares of
few hours ago ago
Traded for 92.72
Purchased few shares of
few hours ago ago
Traded for 176.01
Purchased over 200 shares of
few hours ago ago
Traded for 10.63